Biosig Technologies Inc
NASDAQ:BSGM
Balance Sheet
Balance Sheet Decomposition
Biosig Technologies Inc
Current Assets | 528k |
Cash & Short-Term Investments | 293k |
Receivables | 24k |
Other Current Assets | 211k |
Non-Current Assets | 1.3m |
Long-Term Investments | 17k |
PP&E | 921k |
Intangibles | 289k |
Other Non-Current Assets | 43k |
Current Liabilities | 4.6m |
Accrued Liabilities | 4.5m |
Other Current Liabilities | 117k |
Non-Current Liabilities | 129k |
Other Non-Current Liabilities | 129k |
Balance Sheet
Biosig Technologies Inc
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
0
|
1
|
1
|
2
|
4
|
12
|
28
|
12
|
0
|
0
|
|
Cash |
0
|
1
|
1
|
2
|
4
|
12
|
28
|
12
|
0
|
0
|
|
Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
0
|
0
|
|
Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Current Assets |
0
|
1
|
1
|
2
|
5
|
13
|
29
|
14
|
1
|
1
|
|
PP&E Net |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
PP&E Gross |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
|
Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
Total Assets |
0
N/A
|
1
+194%
|
1
+20%
|
2
+37%
|
5
+194%
|
14
+184%
|
30
+114%
|
16
-49%
|
4
-74%
|
2
-56%
|
|
Liabilities | |||||||||||
Accounts Payable |
1
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
2
|
5
|
2
|
3
|
4
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
1
|
2
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Current Liabilities |
1
|
2
|
3
|
4
|
1
|
2
|
5
|
3
|
3
|
5
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Minority Interest |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
|
Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Liabilities |
1
N/A
|
2
+101%
|
3
+20%
|
4
+34%
|
1
-70%
|
3
+138%
|
6
+107%
|
3
-46%
|
4
+16%
|
5
+28%
|
|
Equity | |||||||||||
Common Stock |
3
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
23
|
32
|
44
|
57
|
71
|
105
|
157
|
189
|
216
|
245
|
|
Additional Paid In Capital |
19
|
29
|
41
|
53
|
74
|
116
|
181
|
201
|
216
|
242
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Equity |
1
N/A
|
1
-66%
|
2
-19%
|
2
-31%
|
4
N/A
|
11
+199%
|
24
+115%
|
12
-50%
|
0
-97%
|
3
N/A
|
|
Total Liabilities & Equity |
0
N/A
|
1
+194%
|
1
+20%
|
2
+37%
|
5
+194%
|
14
+184%
|
30
+114%
|
16
-49%
|
4
-74%
|
2
-56%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
4
|
7
|
9
|
12
|
17
|
23
|
31
|
36
|
55
|
9
|
|
Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|